Microsoft COO Carolina Dybeck Happe said the principle of kaizen is key to how she's approaching AI transformation inside the organization. ...

Oracle is among a consortium of firms that would enable TikTok to continue operations in the United States if a framework deal between the U.S. and China is finalized, CBS News reported on Monday. ...

What Now: You may be eligible to participate in the class action against Tronox Holdings PLC. Shareholders who wish to serve as lead plaintiff for the class must file their papers with the court by November 3, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here ...

I'm a personal investor. I am a financial journalist with special knowledge of the real estate market. I also closely follow technology stocks. I would like to mention that I'm a friend of Ignacio Zorzoli, an article writer for Seeking Alpha, but we don't have any business or economic associations. I cover different sectors and companies than he does, and all the articles published reflect my opinions. I live in Buenos Aires, Argentina, and have over 10 years of experience in communications. I have worked f ...

The Trump administration late Monday ordered Delta Air Lines Inc. and Mexico's Grupo Aeromexico to end their joint venture, claiming it is "anticompetitive.†...

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegati ...

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets technology products and services that assist its customers in evaluating and treating chronic diseases. For more information, su ...

Faraday Future to Present at the Sidoti Small-Cap Virtual Conference on September 18th, 2025 Jerry Wang, Global President of Faraday Future, will present in the upcoming Sidoti Small-Cap Virtual Conference, taking place from September 17-18, 2025, and will deliver a Company presentation and participate in an investor Q&A at the event. Jerry Wang, Global President of Faraday Future, will present in the upcoming Sidoti Small-Cap Virtual Conference, taking place from September 17-18, 2025, and will deliver ...

NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- WHY: September 15, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Tronox Holdings plc (NYSE: TROX) between February 12, 2025 and July 30, 2025, both dates inclusive (the “Class Period”), of the important November 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Tronox common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

Company Overview - Synopsys, Inc. is a technology company specializing in the design and verification of silicon chips for the semiconductor design and manufacturing industry [3]. Allegations and Financial Impact - On September 9, 2025, Synopsys reported missing its prior guidance on earnings per share and revenue for the third quarter of 2025, attributing the disappointing results to "new export restrictions" and disruptions with a major foundry customer [4]. - The company also cited "certain roadmap and resource decisions that did not yield their intended results" as contributing factors to the negative financial performance [4]. Stock Market Reaction - Following the announcement of the missed guidance, Synopsys' stock price fell by $216.59 per share, or 35.8%, closing at $387.78 per share on September 10, 2025 [5].